Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital Microscopy

The aim of this study was to evaluate a robust magnetic resonance (MR) vessel size imaging (VSI) method for the noninvasive assessment of mean vessel size in solid tumors in a clinical dose range of ultrasmall superparamagnetic particles of iron oxide (USPIO). Therefore, USPIO-enhanced MR-VSI was pe...

Full description

Saved in:
Bibliographic Details
Main Authors: Thorsten Persigehl, Janine Ring, Tymoteusz Budny, Anke Hahnenkamp, Sandra Stoeppeler, Lawrence H. Schwartz, Hans-Ullrich Spiegel, Walter Heindel, Stefanie Remmele, Christoph Bremer
Format: Article
Language:English
Published: SAGE Publishing 2013-10-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2013.00059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563168940228608
author Thorsten Persigehl
Janine Ring
Tymoteusz Budny
Anke Hahnenkamp
Sandra Stoeppeler
Lawrence H. Schwartz
Hans-Ullrich Spiegel
Walter Heindel
Stefanie Remmele
Christoph Bremer
author_facet Thorsten Persigehl
Janine Ring
Tymoteusz Budny
Anke Hahnenkamp
Sandra Stoeppeler
Lawrence H. Schwartz
Hans-Ullrich Spiegel
Walter Heindel
Stefanie Remmele
Christoph Bremer
author_sort Thorsten Persigehl
collection DOAJ
description The aim of this study was to evaluate a robust magnetic resonance (MR) vessel size imaging (VSI) method for the noninvasive assessment of mean vessel size in solid tumors in a clinical dose range of ultrasmall superparamagnetic particles of iron oxide (USPIO). Therefore, USPIO-enhanced MR-VSI was performed on DU-4475, MDA-MB-435, and EOMA tumor–bearing mice xenografts with known differences in angiogenic activity and vessel morphology. MR results were compared to vessel sizes determined by immunohistochemistry (anti-CD31) and by intravital microscopy (IVM). MR-VSI revealed significantly different mean vessel sizes between the xenograft models at both USPIO doses (DU-4475: 20.6 ± 4.9 mm; MDA-MB-435: 37.4 ± 8.8 μm; and EOMA: 60.3 ± 9.6 μm at 80 μmol/kg; p < .05). Immunohistochemistry revealed lower values for all tumor entities, whereas the size distribution was in line with MR-measurements. IVM corroborated the MR results for DU-4475 and MDA-MB435, but showed similar vessel sizes for MDA-MB-435 and EOMA. Our MR-VSI method allowed a noninvasive estimation of the mean vessel size in mice xenograft solid tumors with variable vascularity using a clinically relevant USPIO dose range.
format Article
id doaj-art-b97af071a0a94d08aa40f95d89d42305
institution Kabale University
issn 1536-0121
language English
publishDate 2013-10-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-b97af071a0a94d08aa40f95d89d423052025-01-03T00:11:02ZengSAGE PublishingMolecular Imaging1536-01212013-10-011210.2310/7290.2013.0005910.2310_7290.2013.00059Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital MicroscopyThorsten PersigehlJanine RingTymoteusz BudnyAnke HahnenkampSandra StoeppelerLawrence H. SchwartzHans-Ullrich SpiegelWalter HeindelStefanie RemmeleChristoph BremerThe aim of this study was to evaluate a robust magnetic resonance (MR) vessel size imaging (VSI) method for the noninvasive assessment of mean vessel size in solid tumors in a clinical dose range of ultrasmall superparamagnetic particles of iron oxide (USPIO). Therefore, USPIO-enhanced MR-VSI was performed on DU-4475, MDA-MB-435, and EOMA tumor–bearing mice xenografts with known differences in angiogenic activity and vessel morphology. MR results were compared to vessel sizes determined by immunohistochemistry (anti-CD31) and by intravital microscopy (IVM). MR-VSI revealed significantly different mean vessel sizes between the xenograft models at both USPIO doses (DU-4475: 20.6 ± 4.9 mm; MDA-MB-435: 37.4 ± 8.8 μm; and EOMA: 60.3 ± 9.6 μm at 80 μmol/kg; p < .05). Immunohistochemistry revealed lower values for all tumor entities, whereas the size distribution was in line with MR-measurements. IVM corroborated the MR results for DU-4475 and MDA-MB435, but showed similar vessel sizes for MDA-MB-435 and EOMA. Our MR-VSI method allowed a noninvasive estimation of the mean vessel size in mice xenograft solid tumors with variable vascularity using a clinically relevant USPIO dose range.https://doi.org/10.2310/7290.2013.00059
spellingShingle Thorsten Persigehl
Janine Ring
Tymoteusz Budny
Anke Hahnenkamp
Sandra Stoeppeler
Lawrence H. Schwartz
Hans-Ullrich Spiegel
Walter Heindel
Stefanie Remmele
Christoph Bremer
Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital Microscopy
Molecular Imaging
title Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital Microscopy
title_full Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital Microscopy
title_fullStr Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital Microscopy
title_full_unstemmed Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital Microscopy
title_short Vessel Size Imaging (VSI) by Robust Magnetic Resonance (MR) Relaxometry: MR-VSI of Solid Tumors in Correlation with Immunohistology and Intravital Microscopy
title_sort vessel size imaging vsi by robust magnetic resonance mr relaxometry mr vsi of solid tumors in correlation with immunohistology and intravital microscopy
url https://doi.org/10.2310/7290.2013.00059
work_keys_str_mv AT thorstenpersigehl vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT janinering vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT tymoteuszbudny vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT ankehahnenkamp vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT sandrastoeppeler vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT lawrencehschwartz vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT hansullrichspiegel vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT walterheindel vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT stefanieremmele vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy
AT christophbremer vesselsizeimagingvsibyrobustmagneticresonancemrrelaxometrymrvsiofsolidtumorsincorrelationwithimmunohistologyandintravitalmicroscopy